Mosunetuzumab as salvage therapy for refractory connective tissue diseases: clinical responses and immunological insights

Annals of the Rheumatic Diseases · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles